Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients

Shinpei Tsuchida, Hironobu Tsubouchi, Akiko Kitamura, Nobuhiro Matsumoto, Masamitsu Nakazato
European Respiratory Journal 2016 48: PA4842; DOI: 10.1183/13993003.congress-2016.PA4842
Shinpei Tsuchida
1Department of Internal Medicine, University of Miyazaki, Miyazaki-shi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hironobu Tsubouchi
1Department of Internal Medicine, University of Miyazaki, Miyazaki-shi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akiko Kitamura
1Department of Internal Medicine, University of Miyazaki, Miyazaki-shi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nobuhiro Matsumoto
1Department of Internal Medicine, University of Miyazaki, Miyazaki-shi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masamitsu Nakazato
1Department of Internal Medicine, University of Miyazaki, Miyazaki-shi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Introduction Febrile neutropenia (FN) is one of the life threatening complications in cancer patients undergoing chemotherapy. Several comorbidities that are related to chronic inflammation, such as chronic obstructive pulmonary disease (COPD), cholecystolithiasis and dental caries, may influence the risk of FN, but few reports are available on these correlations.

Aims To assess the risk factors of chemotherapy-induced FN in lung cancer patients, we respectively analyzed the correlation between the incidence of FN and chronic comorbidities.

Methods This study was a retrospective analysis of lung cancer patients treated with systemic chemotherapy at University of miyazaki hospital between April 2010 and December 2015. The history of comorbidities and FN events were identified using electronic medical records. The definition of FN was used the criteria of CTCAE (ver. 4.0).

Results This study was conducted with 270 patients (mean age of 65.2±9.4 years) as the subject. 46 cases (17%) developed FN for the duration of chemotherapy. The histological types of lung cancer were small cell lung cancer (n = 77), adenocarcinoma (n = 122), squamous cell carcinoma (n = 41), and other types (n = 30). COPD [odds ratio (OR) = 2.5, 95%Confidence interval (CI) = 1.16–5.38, p = 0.02) was associated with a significantly increased FN risk. Cholecystolithiasis [OR = 1.47, 95%CI = 0.32–6.68, p = 0.61], sinusitis [OR = 1.03, 95%CI = 0.29–3.71, p = 1.00], constipation [OR = 1.47, 95%CI = 0.32–6.68, p = 0.61] and dental caries [OR = 1.17, 95%CI = 0.43–3.21, p = 1.00] had no significant association with FN.

Conclusions COPD is reliable predictor to evaluate risk of chemotherapy-induced FN in the lung cancer patients.

  • Treatments
  • Lung cancer / Oncology
  • Comorbidities
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients
Shinpei Tsuchida, Hironobu Tsubouchi, Akiko Kitamura, Nobuhiro Matsumoto, Masamitsu Nakazato
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4842; DOI: 10.1183/13993003.congress-2016.PA4842

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients
Shinpei Tsuchida, Hironobu Tsubouchi, Akiko Kitamura, Nobuhiro Matsumoto, Masamitsu Nakazato
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4842; DOI: 10.1183/13993003.congress-2016.PA4842
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • A case with a primary adrenal insufficiency secondary to nivolumab
  • Management of residual pleural space and persistent airleak after major lung resection
  • Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients
Show more 11.1 Lung Cancer

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society